The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that sugg...

Pfizer-BioNTech's vaccine, which has been approved for European Union use in teenagers between 12 and 17 years old since May, will be given...

The government was well ahead of the decision, procuring enough doses for the children in the 5-11 age group and beginning to ship them acr...

India is reluctant to provide such overseas indemnity but is in talks for an early resolution to facilitate the supply of the Pfizer-BioNTe...

The research, published in the journal Nature Communications on June 28, found that the immune response was as strong against the Alpha var...

The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed...

However, the vaccine is not yet available in Brazil, which is so far using two others: Chinese-developed CoronaVac and one developed by Oxf...

The Pfizer Inc. and BioNTech SE Covid-19 vaccine appeared to stop the vast majority of recipients in Israel becoming infected, providing th...

In its response, Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided...

According to government sources, while Pfizer had sought clinical trial waiver for its vaccine, the SEC did not considered its proposal and...

The FDA official said that one component of the vaccine, polyethylene glycol, may be the cause of the allergic reactions seen in both the U...

An emergency use authorisation (EUA) is short of a full approval. Pfizer would have to file a separate application for full FDA approval fo...

The firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the ...

"Today's Emergency Use Authorisation in the UK marks a historic moment in the fight against Covid-19," said Pfizer CEO Albert Bourla.

It said the updated analysis was based on 8,000 trial participants. Pfizer said in a previous analysis that 3.7 per cent of 6,000 volunteer...

At end of trading Friday top 10 clients were cumulatively short by 2825 contracts against their counterparts who were long 1743 contracts. ...

Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large s...